RN Levy
About
In The Last Decade
RN Levy
7 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Genetics 2.2k
- Pathology and Forensic Medicine 1.6k
- Immunology 1.2k
- Hematology 535
- Molecular Biology 386
Countries citing papers authored by RN Levy
This map shows the geographic impact of RN Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RN Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RN Levy more than expected).
Fields of papers citing papers by RN Levy
This network shows the impact of papers produced by RN Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RN Levy. The network helps show where RN Levy may publish in the future.
Co-authorship network of co-authors of RN Levy
This figure shows the co-authorship network connecting the top 25 collaborators of RN Levy. A scholar is included among the top collaborators of RN Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RN Levy. RN Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 225 | |
| 2 | 8 | |
| 3 | Clinical staging of chronic lymphocytic leukemia breakdown → | 2059 |
| 4 | 226 | |
| 5 | Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia. | 3 |
| 6 | Daunorubicin (NSC-83142) versus daunorubicin plus prednisone (NSC-10023) versus daunorubicin plus vincristine (NSC-67574) plus prednisone in advanced childhood acute lymphocytic leukemia. | 6 |
| 7 | Therapy of polycythemia vera with radiotytrium (Y-90). | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.